What Researchers Did
Researchers followed a 12-year-old diabetic girl with rhino-orbital-cerebral mucormycosis for 30 months after successful treatment with posaconazole.
What They Found
The patient showed improvement within 10 days of starting posaconazole, experiencing reduced ocular swelling and pain. After 30 months of follow-up, including 6 months post-therapy, she remained in good health with sterile cultures, suggesting the long-term posaconazole therapy was effective.
What This Means for Canadian Patients
This case suggests that long-term posaconazole could be a beneficial treatment option for severe mucormycosis in diabetic children. It also highlights the critical importance of proper diabetes management to prevent such opportunistic fungal infections in vulnerable patients.
Canadian Relevance
This study has no direct Canadian connection.
Study Limitations
A primary limitation of this study is that it reports on a single case, which limits the generalizability of its findings to a broader patient population.